Clinical Effectiveness of Quetiapine in Children and Adolescents with Tourette???s Syndrome
Authors:
- 1 January 2007
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 27 (2) , 123-130
Abstract
Background and objective: Tourette’s syndrome is a relatively common biological genetic disorder with a broad spectrum of neurobehavioural manifestations. Unfortunately, treatment of the condition is often unsatisfactory and all available drugs are associated with potential adverse effects. We therefore aimed to investigate the efficacy of quetiapine, a newer atypical antipsychotic, in the treatment of children and adolescents with Tourette’s syndrome. Methods: This was a retrospective study carried out in outpatient clinics. Twelve patients aged 8–18 years with Tourette’s syndrome (diagnosed according to Diagnostic and Statistical Manual IV criteria) who were receiving quetiapine therapy and had no diagnosis of epilepsy, major depression or psychotic disorder, were included in the study. The main outcome measure was the Yale Global Tic Severity Scale (YGTSS) score. Results: The initial dose of quetiapine was 25 mg/day, but the mean dose was increased to 114.6 ±51.6 mg/day and 175.0 ±116.8 mg/day at the fourth and eighth weeks of treatment, respectively. The YGTSS score, which was 21.6 ±4.0 at baseline, showed significant decreases at 4 and 8 weeks (reducing to 7.5 ±7.4 and 5.6 ±8.1, respectively; p < 0.003). Routine laboratory parameters and serum prolactin level were all normal and did not change throughout treatment. Mild but significant increases in both bodyweight and body mass index at 4 and 8 weeks compared with baseline were observed. Conclusion: Other than causing mild weight gain, quetiapine appears to be an effective, safe and well tolerated drug in children and adolescents with Tourette’s syndrome.Keywords
This publication has 45 references indexed in Scilit:
- Tourette syndrome and other tic disorders in a total population of children: Clinical assessment and backgroundActa Paediatrica, 2005
- Atypical mood stabilizers: a ‘typical’ role for atypical antipsychoticsActa Psychiatrica Scandinavica, 2005
- Effectiveness and Safety of Risperidone for Children and Adolescents with Chronic Tic or Tourette Disorders in KoreaJournal of Child and Adolescent Psychopharmacology, 2005
- Weight Gain Associated with Atypical Antipsychotic Use in Children and AdolescentsPediatric Drugs, 2004
- Quetiapine Treatment of Children and Adolescents with Tourette's DisorderJournal of Child and Adolescent Psychopharmacology, 2003
- Prevalence of tic disorders and Tourette syndrome in a Swedish school populationDevelopmental Medicine & Child Neurology, 2003
- The treatment of Tourette’s syndrome: current opinionsExpert Opinion on Pharmacotherapy, 2002
- Quetiapine Treatment of Children with Tourette's Syndrome: Report of Two CasesJournal of Child and Adolescent Psychopharmacology, 2001
- The long-term effect of quetiapine (Seroquel TM ) monotherapy on weight in patients with schizophreniaInternational Journal of Psychiatry in Clinical Practice, 2000
- Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open studyPsychological Medicine, 1997